Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.
Despite the effectiveness of prophylaxis, Pneumocystis jirovecii pneumonia (PCP) continues to be the most common serious opportunistic infection among HIV-infected persons. We describe factors associated with nonadherence to primary PCP prophylaxis.We used 2000-2004 data from the Supplement to HIV/A...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2656642?pdf=render |
_version_ | 1818510505593012224 |
---|---|
author | James D Heffelfinger Andrew C Voetsch Glenn V Nakamura Patrick S Sullivan A D McNaghten Laurence Huang |
author_facet | James D Heffelfinger Andrew C Voetsch Glenn V Nakamura Patrick S Sullivan A D McNaghten Laurence Huang |
author_sort | James D Heffelfinger |
collection | DOAJ |
description | Despite the effectiveness of prophylaxis, Pneumocystis jirovecii pneumonia (PCP) continues to be the most common serious opportunistic infection among HIV-infected persons. We describe factors associated with nonadherence to primary PCP prophylaxis.We used 2000-2004 data from the Supplement to HIV/AIDS Surveillance (SHAS) project, a cross-sectional interview project of HIV-infected persons >or=18 years conducted in 18 states. We limited the analysis to persons who denied having prior PCP, reported having a current prescription to prevent PCP, and answered the question "In the past 30 days, how often were you able to take the PCP medication(s) exactly the way your doctor told you to take them?" We used multivariable logistic regression to describe factors associated with nonadherence. Of 1,666 subjects prescribed PCP prophylaxis, 305 (18.3%) were nonadherent. Persons were more likely to be nonadherent if they reported using marijuana (adjusted odds ratio [aOR] = 1.6, 95% confidence interval [CI] = 1.1-2.4), non-injection drugs other than marijuana (aOR = 1.5, 95% CI = 1.0-2.1), or injection drugs (aOR = 2.3, 95% CI = 1.3-4.1) in the past year; their mental health was "not good" for >or=1 day during the past month (aOR = 1.6, 95% CI = 1.2-2.2); their most recent CD4 count was <200 cells/microL (aOR = 1.6, 95% CI = 1.1-2.2); or taking ART usually (aOR = 9.6, 95% CI = 6.7-13.7) or sometimes/rarely/never (aOR = 18.4, 95% CI = 11.1-30.4), compared with always, as prescribed.Providers should inquire about and promote strategies to improve adherence to PCP prophylaxis, particularly among persons who use illicit drugs, have mental health issues, and who are not compliant with ART to reduce the occurrence of PCP. |
first_indexed | 2024-12-10T23:20:53Z |
format | Article |
id | doaj.art-4abedc1a12ae49b9adb2d228fb6f2aa4 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-10T23:20:53Z |
publishDate | 2009-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-4abedc1a12ae49b9adb2d228fb6f2aa42022-12-22T01:29:43ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-01-0143e500210.1371/journal.pone.0005002Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.James D HeffelfingerAndrew C VoetschGlenn V NakamuraPatrick S SullivanA D McNaghtenLaurence HuangDespite the effectiveness of prophylaxis, Pneumocystis jirovecii pneumonia (PCP) continues to be the most common serious opportunistic infection among HIV-infected persons. We describe factors associated with nonadherence to primary PCP prophylaxis.We used 2000-2004 data from the Supplement to HIV/AIDS Surveillance (SHAS) project, a cross-sectional interview project of HIV-infected persons >or=18 years conducted in 18 states. We limited the analysis to persons who denied having prior PCP, reported having a current prescription to prevent PCP, and answered the question "In the past 30 days, how often were you able to take the PCP medication(s) exactly the way your doctor told you to take them?" We used multivariable logistic regression to describe factors associated with nonadherence. Of 1,666 subjects prescribed PCP prophylaxis, 305 (18.3%) were nonadherent. Persons were more likely to be nonadherent if they reported using marijuana (adjusted odds ratio [aOR] = 1.6, 95% confidence interval [CI] = 1.1-2.4), non-injection drugs other than marijuana (aOR = 1.5, 95% CI = 1.0-2.1), or injection drugs (aOR = 2.3, 95% CI = 1.3-4.1) in the past year; their mental health was "not good" for >or=1 day during the past month (aOR = 1.6, 95% CI = 1.2-2.2); their most recent CD4 count was <200 cells/microL (aOR = 1.6, 95% CI = 1.1-2.2); or taking ART usually (aOR = 9.6, 95% CI = 6.7-13.7) or sometimes/rarely/never (aOR = 18.4, 95% CI = 11.1-30.4), compared with always, as prescribed.Providers should inquire about and promote strategies to improve adherence to PCP prophylaxis, particularly among persons who use illicit drugs, have mental health issues, and who are not compliant with ART to reduce the occurrence of PCP.http://europepmc.org/articles/PMC2656642?pdf=render |
spellingShingle | James D Heffelfinger Andrew C Voetsch Glenn V Nakamura Patrick S Sullivan A D McNaghten Laurence Huang Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia. PLoS ONE |
title | Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia. |
title_full | Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia. |
title_fullStr | Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia. |
title_full_unstemmed | Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia. |
title_short | Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia. |
title_sort | nonadherence to primary prophylaxis against pneumocystis jirovecii pneumonia |
url | http://europepmc.org/articles/PMC2656642?pdf=render |
work_keys_str_mv | AT jamesdheffelfinger nonadherencetoprimaryprophylaxisagainstpneumocystisjiroveciipneumonia AT andrewcvoetsch nonadherencetoprimaryprophylaxisagainstpneumocystisjiroveciipneumonia AT glennvnakamura nonadherencetoprimaryprophylaxisagainstpneumocystisjiroveciipneumonia AT patrickssullivan nonadherencetoprimaryprophylaxisagainstpneumocystisjiroveciipneumonia AT admcnaghten nonadherencetoprimaryprophylaxisagainstpneumocystisjiroveciipneumonia AT laurencehuang nonadherencetoprimaryprophylaxisagainstpneumocystisjiroveciipneumonia |